Ventyx Biosciences
0 followers
VTYX
Performance
About Ventyx Biosciences
Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for autoimmune, inflammatory, and neurodegenerative diseases. The company leverages medicinal chemistry, structural biology, and immunology to discover differentiated small-molecule therapeutics for conditions with high unmet medical need, advancing them through clinical trials. Its lead portfolio includes NLRP3 inhibitors such as VTX2735 (peripherally restricted) and VTX3232 (CNS-penetrant) in Phase 2 development, along with tamuzimod (S1P1R modulator) and VTX958 (TYK2 inhibitor) in various stages of clinical testing.